To the Editor: As of April 20, 2020, over 2 million infections by the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) have been reported and 166 256 people have died from corona virus disease 2019 (COVID-19).1-4 As the surge continues, the management of neurosurgical patients infected with SARSCoV-2 may become increasingly complex due to competing therapeutic goals. We describe the perioperative and neurocritical care management of the first reported patient with asymptomatic SARS-CoV-2 infection and aneurysmal subarachnoid hemorrhage (aSAH).

中文翻译：

---

信件：严重急性呼吸系统综合症冠状病毒 2 感染和动脉瘤性蛛网膜下腔出血患者的围手术期和重症监护管理

致编辑：截至 2020 年 4 月 20 日，已报告超过 200 万例严重急性呼吸系统综合症冠状病毒 2（SARS-CoV-2）感染，166256 人死于 2019 冠状病毒病（COVID-19） .1-4 随着激增的继续，感染 SARSCoV-2 的神经外科患者的管理可能会因相互竞争的治疗目标而变得越来越复杂。我们描述了首例无症状 SARS-CoV-2 感染和动脉瘤性蛛网膜下腔出血 (aSAH) 患者的围手术期和神经重症监护管理。